Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...
MedPage Today on MSN
Ocrelizumab May Double Serious Infection Risk in MS
Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS ...
Designed to unlock potential value by creating two independent, publicly traded companies with different business objectives and ...
From 1 September 2025, a significant expansion of voluntary interferon-gamma blood testing has been available to cattle ...
Cocoa flavanol supplements reduce key inflammatory markers linked to ageing and heart disease. Keep reading to learn their ...
Bernstein 2nd Annual Global Healthcare Conference September 23, 2025 1:58 PM EDTCompany ParticipantsMatthew Gline - ...
Almost half of women with MS remain untreated during family planning, though ocrelizumab is the most commonly used DMT in this population.
Bernstein 2nd Annual Global Healthcare Conference September 24, 2025 11:20 AM EDTCompany ParticipantsPriya Singhal - Executive ...
Discover how zinc-rich foods and proper intake strengthen immunity, enhance skin repair, and protect against global ...
Background Multiple sclerosis (MS) is a common autoimmune illness that causes inflammation, demyelination and neurological damage. Symptom relief and immunotherapy are part of the treatment, but ...
Patent supports AIM's strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is the third-largest pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback